Comments
Loading...

Veracyte Stock Guidance

VCYTNASDAQ
Logo brought to you by Benzinga Data
$30.35
0.642.15%
At close: -
$30.00
-0.35-1.15%
After Hours: May 2, 6:01 PM EDT
Q1 2025 Earnings in 3 days from now on Wed May 7th, after the market close
Conference call scheduled in 3 days at 16:30 PM Click to view the webcast

Veracyte Stock Guidance | NASDAQ:VCYT | Benzinga

Veracyte issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/06/2024VCYT
Veracyte
FY2024———$442.00M$445.00M$436.14MGet Alert
08/06/2024VCYT
Veracyte
FY2024———$432.00M$438.00M$406.27MGet Alert
05/07/2024VCYT
Veracyte
FY2024———$402.00M$410.00M$397.84MGet Alert
02/22/2024VCYT
Veracyte
FY2024———$394.00M$402.00M$393.28MGet Alert
01/08/2024VCYT
Veracyte
FY2024———$394.00M$402.00M$391.50MGet Alert
01/08/2024VCYT
Veracyte
FY2023———$358.00M$359.00M$352.78MGet Alert
01/08/2024VCYT
Veracyte
Q42023———$95.00M$96.00M$89.91MGet Alert
11/07/2023VCYT
Veracyte
FY2023———$352.00M$354.00M$346.89MGet Alert
08/08/2023VCYT
Veracyte
FY2023———$342.00M$350.00M$335.77MGet Alert
05/04/2023VCYT
Veracyte
FY2023———$330.00M$340.00M$330.51MGet Alert
02/22/2023VCYT
Veracyte
FY2023———$325.00M$335.00M$329.57MGet Alert
11/02/2022VCYT
Veracyte
FY2022———$288.00M$293.00M$277.79MGet Alert
08/02/2022VCYT
Veracyte
FY2022———$272.00M$280.00M$272.42MGet Alert
05/03/2022VCYT
Veracyte
FY2022———$265.00M$275.00M$270.30MGet Alert
02/28/2022VCYT
Veracyte
FY2022———$260.00M$275.00M$268.02MGet Alert
11/09/2021VCYT
Veracyte
FY2021———$210.00M$218.00M$205.88MGet Alert
07/29/2021VCYT
Veracyte
FY2021———$200.00M$208.00M$197.90MGet Alert
05/10/2021VCYT
Veracyte
FY2021———$190.00M$200.00M$194.19MGet Alert
04/15/2021VCYT
Veracyte
Q12021———$36.00M$37.00M$32.03MGet Alert
02/03/2021VCYT
Veracyte
Q42020———$34.00M$35.00M$33.49MGet Alert
02/03/2021VCYT
Veracyte
FY2020———$117.00M$118.00M$114.90MGet Alert

FAQ

Q

What is the most recent guidance for Veracyte (VCYT)?

A

There have been no specific sales or earnings guidance reported for Veracyte in recent months.

Browse guidance and forecast on all stocks.

People Also Watch